Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer's Disease

Overview

Journal Cell Rep

Publisher Cell Press

Specialties Biology
Cell Biology
Molecular Biology

Date 2018 Dec 28

PMID 30590039

Citations 71

Authors

Christy O Y Hung

Frederick J Livesey

Affiliations

Soon will be listed here.

Abstract

Abnormalities of the endolysosomal and autophagy systems are found in Alzheimer's disease, but it is not clear whether defects in these systems are a cause or consequence of degenerative processes in the disease. In human neuronal models of monogenic Alzheimer's disease, APP and PSEN1 mutations disrupt lysosome function and autophagy, leading to impaired lysosomal proteolysis and defective autophagosome clearance. Processing of APP by γ-secretase is central to the pathogenic changes in the lysosome-autophagy system caused by PSEN1 and APP mutations: reducing production of C-terminal APP by inhibition of BACE1 rescued these phenotypes in both APP and PSEN1 mutant neurons, whereas inhibition of γ-secretase induced lysosomal and autophagic pathology in healthy neurons. Defects in lysosomes and autophagy due to PSEN1 mutations are rescued by CRISPR-knockout of APP. These data demonstrate a key role for proteolysis of the C-terminal of APP by γ-secretase in neuronal dysfunction in monogenic Alzheimer's disease.

Citing Articles

Presenilins as hub proteins controlling the endocytic and autophagic pathways and small extracellular vesicle secretion.

Lauritzen I, Bini A, Becot A, Gay A, Badot C, Pagnotta S J Extracell Vesicles. 2025; 14(1):e70019.

PMID: 39815792 PMC: 11735957. DOI: 10.1002/jev2.70019.

Clearance of beta-amyloid and tau aggregates is size dependent and altered by an inflammatory challenge.

Fertan E, Hung C, Danial J, Lam J, Preman P, Albertini G Brain Commun. 2025; 7(1):fcae454.

PMID: 39749010 PMC: 11694676. DOI: 10.1093/braincomms/fcae454.

Altered expression of Presenilin2 impacts endolysosomal homeostasis and synapse function in Alzheimer's disease-relevant brain circuits.

Perdok A, Van Acker Z, Vrancx C, Sannerud R, Vorsters I, Verrengia A Nat Commun. 2024; 15(1):10412.

PMID: 39613768 PMC: 11607342. DOI: 10.1038/s41467-024-54777-y.

Mitochondrial dysfunction, cause or consequence in neurodegenerative diseases?.

Van Acker Z, Leroy T, Annaert W Bioessays. 2024; 47(1):e2400023.

PMID: 39367555 PMC: 11662158. DOI: 10.1002/bies.202400023.

Pathophysiologic abnormalities in transgenic mice carrying the Alzheimer disease PSEN1 Δ440 mutation.

Fuller P, Collis V, Sharma P, Burkett A, Wang S, Brown K Hum Mol Genet. 2024; 33(23):2051-2070.

PMID: 39323410 PMC: 11578115. DOI: 10.1093/hmg/ddae139.

References

Jonsson T, Atwal J, Steinberg S, Snaedal J, Jonsson P, Bjornsson S . A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature. 2012; 488(7409):96-9. DOI: 10.1038/nature11283. View

Chen C, Chen W, Zhou M, Arttamangkul S, Haugland R . Probing the cathepsin D using a BODIPY FL-pepstatin A: applications in fluorescence polarization and microscopy. J Biochem Biophys Methods. 2000; 42(3):137-51. DOI: 10.1016/s0165-022x(00)00048-8. View

Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

Chavez-Gutierrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M . The mechanism of γ-Secretase dysfunction in familial Alzheimer disease. EMBO J. 2012; 31(10):2261-74. PMC: 3364747. DOI: 10.1038/emboj.2012.79. View

Lauritzen I, Pardossi-Piquard R, Bourgeois A, Pagnotta S, Biferi M, Barkats M . Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology. Acta Neuropathol. 2016; 132(2):257-276. PMC: 4947121. DOI: 10.1007/s00401-016-1577-6. View

Chiang T, le Sage C, Larrieu D, Demir M, Jackson S . CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing. Sci Rep. 2016; 6:24356. PMC: 4832145. DOI: 10.1038/srep24356. View

Park I, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A . Disease-specific induced pluripotent stem cells. Cell. 2008; 134(5):877-86. PMC: 2633781. DOI: 10.1016/j.cell.2008.07.041. View

Thinakaran G, Koo E . Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008; 283(44):29615-9. PMC: 2573065. DOI: 10.1074/jbc.R800019200. View

Tinevez J, Perry N, Schindelin J, Hoopes G, Reynolds G, Laplantine E . TrackMate: An open and extensible platform for single-particle tracking. Methods. 2016; 115:80-90. DOI: 10.1016/j.ymeth.2016.09.016. View

10.

Cataldo A, Peterhoff C, Troncoso J, Gomez-Isla T, Hyman B, Nixon R . Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000; 157(1):277-86. PMC: 1850219. DOI: 10.1016/s0002-9440(10)64538-5. View

11.

Spilman P, Podlutskaya N, Hart M, Debnath J, Gorostiza O, Bredesen D . Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One. 2010; 5(4):e9979. PMC: 2848616. DOI: 10.1371/journal.pone.0009979. View

12.

Colacurcio D, Pensalfini A, Jiang Y, Nixon R . Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease. Free Radic Biol Med. 2017; 114:40-51. PMC: 5748263. DOI: 10.1016/j.freeradbiomed.2017.10.001. View

13.

Muratore C, Rice H, Srikanth P, Callahan D, Shin T, Benjamin L . The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. Hum Mol Genet. 2014; 23(13):3523-36. PMC: 4049307. DOI: 10.1093/hmg/ddu064. View

14.

Woodruff G, Reyna S, Dunlap M, van der Kant R, Callender J, Young J . Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer's Disease Mutations. Cell Rep. 2016; 17(3):759-773. PMC: 5796664. DOI: 10.1016/j.celrep.2016.09.034. View

15.

Jiang Y, Mullaney K, Peterhoff C, Che S, Schmidt S, Boyer-Boiteau A . Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci U S A. 2010; 107(4):1630-5. PMC: 2824382. DOI: 10.1073/pnas.0908953107. View

16.

Kayala K, Dickinson G, Minassian A, Walls K, Green K, LaFerla F . Presenilin-null cells have altered two-pore calcium channel expression and lysosomal calcium: implications for lysosomal function. Brain Res. 2012; 1489:8-16. PMC: 3516298. DOI: 10.1016/j.brainres.2012.10.036. View

17.

Tsvetkov A, Miller J, Arrasate M, Wong J, Pleiss M, Finkbeiner S . A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc Natl Acad Sci U S A. 2010; 107(39):16982-7. PMC: 2947884. DOI: 10.1073/pnas.1004498107. View

18.

Nixon R, Wegiel J, Kumar A, Yu W, Peterhoff C, Cataldo A . Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol. 2005; 64(2):113-22. DOI: 10.1093/jnen/64.2.113. View

19.

Majumder S, Richardson A, Strong R, Oddo S . Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS One. 2011; 6(9):e25416. PMC: 3182203. DOI: 10.1371/journal.pone.0025416. View

20.

de Jonghe C, Cruts M, Rogaeva E, Tysoe C, Singleton A, Vanderstichele H . Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. Hum Mol Genet. 1999; 8(8):1529-40. DOI: 10.1093/hmg/8.8.1529. View